Does gut-derived TMA become TMAO mainly through hepatic FMO3, while kidney clearance shapes circulating TMAO?

The claim is strongly supported in humans: circulating trimethylamine N-oxide (TMAO) is the net result of microbial/dietary inputs, hepatic oxidation, and renal elimination—not a direct biomarker of any one step.

Production and hepatic mechanism

• Gut microbial TMA lyases convert dietary choline, phosphatidylcholine, carnitine, and betaine to trimethylamine (TMA). Preformed dietary TMAO, including from fish, can also transiently raise circulating TMAO independently of microbial TMA production.
• After absorption, TMA is oxidized predominantly by hepatic flavin-containing monooxygenase 3 (FMO3). Human liver-microsome and recombinant-enzyme studies indicate FMO3 accounts for at least 90% of hepatic TMA-oxidizing activity.
• Human genetics provides causal corroboration: biallelic loss-of-function or severely hypomorphic FMO3 variants reduce TMAO formation and cause TMA accumulation, as in primary trimethylaminuria.

Renal handling

• Renal filtration is a major determinant of plasma TMAO. In prospective human data, TMAO clearance closely approximated measured GFR, with fractional excretion 105% ± 32%; plasma TMAO inversely correlated with measured GFR (r²=0.388; P<0.001).
• Advanced CKD is associated with 67.9 μmol/L higher TMAO in meta-analytic data. Dialysis-dependent patients had concentrations around 77–94 μmol/L versus ~2–3 μmol/L in healthy controls, with an ~85–86% decline during a dialysis session.

Interpretation in practice

• A single TMAO result cannot distinguish increased microbial/dietary input, altered FMO3 oxidation, distribution, or reduced renal clearance. Approximately 94.5% of administered tracer is recovered in urine within 24 hours, underscoring the importance of elimination.
• Interpretation requires contemporaneous eGFR, recent diet/fasting status, medications, and comorbidity; paired plasma–urine sampling or isotope-tracer kinetics can separate production from clearance more effectively.

Bottom line

• TMA is mainly converted to TMAO by hepatic FMO3, kidney filtration substantially determines circulating TMAO, and one plasma concentration cannot isolate either process.